RELAPSED ACUTE MYELOID LEUKEMIA
Clinical trials for RELAPSED ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for relapsed leukemia: experimental drug combo enters human trials
Disease control Recruiting nowThis early-phase trial is testing a new drug combination for adults whose acute myeloid leukemia (AML) has returned or not responded to prior treatment. The study will first check the safety of adding imetelstat to standard drugs, then find the best dose when a third drug is incl…
Matched conditions: RELAPSED ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Douglas Tremblay • Aim: Disease control
Last updated Apr 29, 2026 03:42 UTC
-
New combo therapy aims to wipe out hard-to-treat leukemia
Disease control Recruiting nowThis study tests whether adding venetoclax to a standard chemotherapy regimen (CLAG-M) can better control acute myeloid leukemia (AML) and related high-grade blood cancers. About 62 adults with newly diagnosed or relapsed/refractory disease will receive the combination. The goal …
Matched conditions: RELAPSED ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 29, 2026 03:40 UTC